Company: BKYI
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001437749-25-026549
Chunk: 2

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
 
         
 STOCKHOLDERS’ EQUITY         
         
 Common stock — authorized, 170,000,000 shares; issued and outstanding; 6,848,776 and 3,715,483 of $.0001 par value at June 30, 2025 and December 31, 2024, respectively   685   372 
 Additional paid-in capital   137,948,437   133,030,271 
 Accumulated other comprehensive income   114,898   49,290 
 Accumulated deficit   (131,211,843)  (129,307,902)
 TOTAL STOCKHOLDERS’ EQUITY   6,852,177   3,772,031 
 TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $10,516,551  $8,615,560 

See accompanying notes to the condensed consolidated financial statements.  

     3

      Table of Contents

BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

       Three Months Ended 

       Six Months Ended 

       June 30, 

       June 30, 

       2025 

       2024 

       2025 

       2024 

       Revenues 

       Services 
       
      $
      321,996

      $
      283,569

      $
      594,594

      $
      496,690

       License fees 

      806,087

      774,225

      1,904,845

      2,724,659

       Hardware 

      568,824

      83,492

      804,627

      101,140

       Total revenues 

      1,696,907

      1,141,286

      3,304,066

      3,322,489

       Costs and other expenses 

       Cost of services 

      118,301

      73,385

      216,445

      212,234

       Cost of license fees 

      86,488

      148,432

      159,373

      296,652

       Cost of hardware 

      536,806

      40,455

      645,275